Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How to give thrombolytic therapy safely.

B C Donovan1

  • 1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston 02115.

Chest
|May 1, 1989
PubMed
Summary

Maximizing safety in thrombolytic therapy requires careful patient selection and monitoring for complications like groin hematomas. Increased patient eligibility for this treatment is possible with proper staff education and familiarization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prolonged bleeding time as a marker of venous clot lysis during streptokinase therapy.

American heart journal·1991
Same author

Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts.

American heart journal·1991
Same author

Program for the prevention of venous thromboembolism in high-risk orthopaedic patients.

The Journal of arthroplasty·1991
Same author

Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.

Radiology·1990

Area of Science:

  • Cardiology
  • Neurology
  • Emergency Medicine

Background:

  • Thrombolytic therapy is a critical treatment for various conditions.
  • Ensuring patient safety during thrombolysis is paramount.
  • Optimal patient selection is key to maximizing therapeutic benefits and minimizing risks.

Purpose of the Study:

  • To outline essential safety measures for thrombolytic therapy.
  • To emphasize the importance of rigorous patient screening for contraindications.
  • To highlight the need for continuous patient monitoring during and after treatment.

Main Methods:

  • Review of contraindications for thrombolytic agents.
  • Guidelines for serial patient examinations, including neurological status and vital signs.
  • Protocols for monitoring potential complications, such as groin hematomas at catheterization sites.

Main Results:

  • Strict adherence to contraindication screening enhances safety.
  • Serial examinations and close monitoring of specific sites can detect early complications.
  • A significant number of patients are potentially eligible for thrombolytic therapy.

Conclusions:

  • Optimal patient selection and vigilant monitoring are crucial for safe thrombolytic therapy.
  • Hospital staff education and familiarization increase confidence and utilization of thrombolysis.
  • Wider application of thrombolytic therapy is feasible with appropriate protocols and training.

Related Experiment Videos